Research On The Selection And Application Of LNS Company's Biological Asset Accounting Measurement Mode

General secretary Xi Jinping put forward that "the Chinese rice bowl must be firmly held in their hands at any time",emphasizing the strategic importance of agriculture to a country’s development.From the accounting point of view,attaching importance to agriculture is to attach importance to the accounting of its biological assets.However,different measurement models will disclose different biological assets information,so it is particularly important to study the measurement model of biological assets.Since 2018,due to the impact of "African swine fever",pig prices have changed dramatically.LUONIUSHAN Co.,Ltd.is a national key leading enterprise of agricultural industrialization,with a certain scale of the company,and the company’s biological assets are mainly pigs.The company’s biological assets income changes significantly affected by the epidemic.Therefore,the company is selected as the research object.Based on the analysis of the current situation of the measurement of biological assets in LNs company,this paper finds that the historical cost measurement mode adopted by LNs company can not reflect the impact of the changes in the value of biological assets on the enterprise value,and the value-added of biological assets in the growth process.On this basis,the necessity of adopting the mixed measurement mode is discussed.At the same time,the solution of mixed measurement mode is proposed,that is,the biological assets are initially measured by historical cost measurement mode,and the subsequent measurement is carried out by fair value measurement mode.Combined with cas39 accounting standards,when measuring the fair value of biological assets in different growth stages,we choose two measurement methods: net present value model and historical cost plus natural value-added model.Then,by comparing the results of the two measurement models,it is concluded that the mixed measurement model can reflect the natural growth of biological assets and is sensitive to the price changes of biological assets compared with the historical cost measurement model,and the relevant safeguards are put forward.